Pain News and Research

Latest Pain News and Research

Caesarean section increases risk of persistent pelvic girdle pain compared with vaginal delivery

Caesarean section increases the risk of persistent pelvic girdle pain after delivery compared with vaginal delivery, according to a new study from the Norwegian Institute of Public Health.

17 Jan 2013

Preterm infants with slower growth have delayed development in the cerebral cortex

Preterm infants who grow more slowly as they approached what would have been their due dates also have slower development in an area of the brain called the cerebral cortex, report Canadian researchers in a new study published today in Science Translational Medicine.

17 Jan 2013

Study identifies subgroups of patients with distinct, persistent pain after breast cancer surgery

Some 25 percent of breast cancer surgery patients experience significant, persistent pain six months after the procedure, and new research published in The Journal of Pain showed that women with preoperative breast pain have the highest risk for extended post-surgical pain.

17 Jan 2013

QrxPharma to resubmit MOXDUO NDA with FDA

QRxPharma Limited announced today that the steps necessary for approval of immediate release MOXDUO have been clarified with the United States Food and Drug Administration (FDA).

17 Jan 2013

State roundup: Maine hospitals fighting for timely Medicaid payments

New York police plan to distribute "bait bottles" of fake pain-killers equipped with invisible GPS devices in a drive to combat the scourge of pharmacy robberies by addicts and sellers looking for oxycodone tablets, which can fetch more than $80 per pill on the street.

17 Jan 2013

People most often visit doctors because of skin issues, joint disorders and back pain

A new Mayo Clinic Proceedings study shows that people most often visit their health care providers because of skin issues, joint disorders and back pain. Findings may help researchers focus efforts to determine better ways to prevent and treat these conditions in large groups of people.

17 Jan 2013

TMD pain might reflect physical manifestation of anxiety or depression

There is an ongoing debate about the role of psychological disorder symptoms as risk factors for temporomandibular joint (TMJ) pain. Previous studies have associated depression and TMJ pain but large scale studies have not been performed.

17 Jan 2013

FDA approves St. Jude Medical’s Merlin.net Patient Care Network

St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of the next-generation Merlin.net Patient Care Network (PCN), a secure, Internet-based remote care system for patients with implanted medical devices.

17 Jan 2013

People with chronic inflammatory conditions may benefit from mindfulness meditation

People suffering from chronic inflammatory conditions, such as rheumatoid arthritis, inflammatory bowel disease and asthma - in which psychological stress plays a major role - may benefit from mindfulness meditation techniques, according to a study by University of Wisconsin-Madison neuroscientists with the Center for Investigating Healthy Minds at the Waisman Center.

17 Jan 2013

Astellas announces FDA acceptance of Tarceva sNDA for EGFR activating mutation-positive NSCLC

Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for Tarceva (erlotinib) for first-line use in people with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) activating mutations.

17 Jan 2013

Protein Sciences receives FDA approval for Flublok vaccine

The U.S. Food and Drug Administration today announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. Flublok is approved for the prevention of seasonal influenza in people 18 through 49 years of age.

16 Jan 2013

First Edition: January 16, 2013

Today's headlines include reports examining how mental health issues play a role in efforts to curb gun violence and expand gun control efforts.

16 Jan 2013

SPECT-CT improves preop foot diagnosis

Research demonstrates the usefulness of radionuclide bone scans with single photon-emission computed tomography and computed tomography for the assessment of patients awaiting foot or angle surgery.

16 Jan 2013

Acetaminophen may improve postoperative outcomes

Prophylactically administered intravenous acetaminophen could reduce postoperative nausea and vomiting, research suggests.

16 Jan 2013

Reviva Pharmaceuticals completes enrollment in RP5063 phase 2 trial for schizophrenia

Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company, today announces completion of patient enrollment in the phase 2 clinical trial of RP5063 for the treatment of schizophrenia and schizoaffective disorder.

16 Jan 2013

FDA approves Santarus’ UCERIS for induction of remission in patients with ulcerative colitis

Santarus, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved UCERIS (budesonide) extended release tablets for the induction of remission in patients with active, mild to moderate ulcerative colitis.

16 Jan 2013

Vanderbilt University, AstraZeneca partner to identify candidate drugs for major brain diseases

Today, AstraZeneca and Vanderbilt University announced they have signed a research collaboration agreement to identify candidate drugs aimed at treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer's disease and schizophrenia.

16 Jan 2013

Pfizer’s Quillivant XR now available in the U.S. for treatment of ADHD

Pfizer Inc. today announced that Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension is now available in the U.S. for the treatment of attention deficit hyperactivity disorder (ADHD).

16 Jan 2013

Viewpoints: Health law's 'sticker shock;' Changing Medicare eligibility age is not a simple solution

President Obama said a fair bit during the fiscal-cliff negotiations - speaking for 45 minutes in one 50-minute meeting, for example - but today let's zero in on the claim he kept repeating: "We don't have a spending problem. We have a health-care problem." For our money - and yours - those are two of the most remarkable sentences our Orator in Chief has ever strung together.

15 Jan 2013

Knee cartilage repair success with new biomaterial

In a small study, researchers reported increased healthy tissue growth after surgical repair of damaged cartilage if they put a “hydrogel” scaffolding into the wound to support and nourish the healing process. The squishy hydrogel material was implanted in 15 patients during standard microfracture surgery, in which tiny holes are punched in a bone near the injured cartilage. The holes stimulate patients’ own specialized stem cells to emerge from bone marrow and grow new cartilage atop the bone.

15 Jan 2013

Pain News and Research

Latest Pain News and Research

Caesarean section increases risk of persistent pelvic girdle pain compared with vaginal delivery

Preterm infants with slower growth have delayed development in the cerebral cortex

Study identifies subgroups of patients with distinct, persistent pain after breast cancer surgery

QrxPharma to resubmit MOXDUO NDA with FDA

State roundup: Maine hospitals fighting for timely Medicaid payments

People most often visit doctors because of skin issues, joint disorders and back pain

TMD pain might reflect physical manifestation of anxiety or depression

FDA approves St. Jude Medical’s Merlin.net Patient Care Network

People with chronic inflammatory conditions may benefit from mindfulness meditation

Astellas announces FDA acceptance of Tarceva sNDA for EGFR activating mutation-positive NSCLC

Protein Sciences receives FDA approval for Flublok vaccine

First Edition: January 16, 2013

SPECT-CT improves preop foot diagnosis

Acetaminophen may improve postoperative outcomes

Reviva Pharmaceuticals completes enrollment in RP5063 phase 2 trial for schizophrenia

FDA approves Santarus’ UCERIS for induction of remission in patients with ulcerative colitis

Vanderbilt University, AstraZeneca partner to identify candidate drugs for major brain diseases

Pfizer’s Quillivant XR now available in the U.S. for treatment of ADHD

Viewpoints: Health law's 'sticker shock;' Changing Medicare eligibility age is not a simple solution

Knee cartilage repair success with new biomaterial

Forensics and toxicology - Industry Focus eBook eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Pain News and Research

Latest Pain News and Research

Forensics and toxicology - Industry Focus eBook eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in